Section 1: IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING 	
 	
1.1  Product identifier  	
Product code 	IKO2100MAC4 	
Product name 	IKO2100MA Magenta 	
Product category 	ECO Series  	
		
1.2  Relevant identified uses of the substance or mixture and uses advised against  	
Recommended use 	Printing operations  	
	
1.3  Details of the supplier of the safety data sheet  	
Atrium Centrum Ploterowe Sp. z o.o. 
45-446 Opole, ul. Gostawicka 2D 
tel.: 77 458 16 81  	

	

For further information, please contact  	
Contact person 	Monika Gajewska  	
E-mail address 	atramenty@atrium.com.pl  	
	
1.4  Emergency telephone number  	
Atrium Centrum: 77 458 16 81  	

Section 2: HAZARDS IDENTIFICATION 	
		
2.1  Classification of the substance or mixture  	
According to Regulation (EC) No 1272/2008  	
Serious eye damage/eye irritation 	Category 1  - (H318)  	
Specific target organ toxicity (single exposure) 	Category 3  - (H336)  	
		
2.2  Label elements  	
	
Signal Word
Danger  	
	
Hazard Statements
H318 - Causes serious eye damage
H336 - May cause drowsiness or dizziness  	
		
Precautionary Statements
P305 + P351 + P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing
P261 - Avoid breathing dust/fume/gas/mist/vapors/spray
P403 + P233 - Store in a well-ventilated place. Keep container tightly closed
P280 - Wear protective gloves/protective clothing/eye protection/face protection  	
		
2.3  Other Hazards  	
	General Hazards 	No information available  	
	
Section 3: COMPOSITION/INFORMATION ON INGREDIENTS 	
		
3.2  Mixtures  	
 	
Component 	EC No. 	CAS-No 	Weight % 	Classification according to Regulation (EC) No. 1272/2008 [CLP] 	REACH No. 	Note 	
Diethylene glycol diethyl ether 	203-963-7 	112-36-7 	30 - 60 	Eye Irrit. 2 (H319) 	01-2119969946-13-xxxx 		
Butyrolactone 	202-509-5 	96-48-0 	10 - 30 	Acute Tox. 4 (H302) 
Eye Dam. 1 (H318) 
STOT SE 3 (H336) 	01-2119471839-21-xxxx 	1 	
Ethylene glycol monobutyl ether acetate 	203-933-3 	112-07-2 	5 - 10 	Acute Tox. 4 (H312) 
Acute Tox. 4 (H332) 	01-2119475112-47-xxxx 	1 	
Triethylene glycol monobutyl ether 	205-592-6 	143-22-6 	1 - 5 	Eye Dam. 1 (H318) 	01-2119475107-38-xxxx 		
Dimethyl succinate 	203-419-9 	106-65-0 	1 - 5 	Not Classified 	01-2119486681-29-xxxx 	1 	
Dimethyl glutarate 	214-277-2 	1119-40-0 	1 - 5 	Not Classified 	01-2119900156-49-xxxx 	1 	
Note
REACH No: Registration number(s) may not be provided because substance(s) are exempted or not yet required to be registered under REACH
1. Substance with a Community workplace exposure limit  	
		
Full text of H- and EUH-phrases: see section 16  	
	
Section 4: FIRST AID MEASURES 	
		
4.1  Description of first aid measures  	
	General Advice 	Show this safety data sheet to the doctor in attendance.  	
	Eye Contact 	Immediately flush with plenty of water. After initial flushing, remove any contact lenses and continue flushing for at least 15 minutes. Get medical attention if irritation develops and persists.  	
	Skin Contact 	Wash off immediately with soap and plenty of water for at least 15 minutes. Remove contaminated clothing. If irritation (redness, rash, blistering) develops, get medical attention.  	
	Inhalation 	Remove person to fresh air and keep comfortable for breathing. If breathing is irregular or stopped, administer artificial respiration. Get medical attention immediately.  	
	Ingestion 	Do NOT induce vomiting. Call a physician or poison control center immediately. Never give anything by mouth to an unconscious person.  	
		
4.2  Most important symptoms and effects, both acute and delayed  	
	None under normal use conditions.  	
	
4.3  Indication of any immediate medical attention and special treatment needed  	
	Notes to Physician 	Treat symptomatically.  	

Section 5: FIRE FIGHTING MEASURES 	
5.1  Extinguishing media  	
	Suitable Extinguishing Media
Foam. Carbon dioxide (CO2). Dry chemical. Water spray. Use extinguishing measures that are appropriate to local circumstances and the surrounding environment.  	
	
	Unsuitable Extinguishing Media
No information available.  	
	
5.2  Special hazards arising from the substance or mixture  	
	Thermal decomposition can lead to release of irritating gases and vapors. May emit toxic fumes under fire conditions.  	
	
5.3  Advice for firefighters  	
	As in any fire, wear self-contained breathing apparatus pressure-demand, MSHA/NIOSH (approved or equivalent) and full protective gear. Cool containers / tanks with water spray. Sealed containers may rupture when heated.  	
	
Section 6: ACCIDENTAL RELEASE MEASURES 	
		
6.1  Personal precautions, protective equipment and emergency procedures  	
	Remove all sources of ignition. Ventilate the area. Avoid contact with eyes, skin and clothing. Avoid breathing dust or vapor. Evacuate personnel to safe areas. Keep people away from and upwind of spill/leak.  	
		
6.2  Environmental precautions  	
	Prevent product from entering drains. Prevent further leakage or spillage if safe to do so. Keep out of drains, sewers, ditches and waterways. Local authorities should be advised if significant spillages cannot be contained.  	
	
6.3  Methods and material for containment and cleaning up  	
	Contain spillage, and then collect with non-combustible absorbent material, (e.g. sand, earth, diatomaceous earth, vermiculite) and place in container for disposal according to local / national regulations (see section 13). Use clean non-sparking tools to collect absorbed material.  	
	
6.4  Reference to other sections  	
	See Section 12 for more information.  	
	
Section 7: HANDLING AND STORAGE 	
		
7.1  Precautions for safe handling  	
	Use personal protective equipment as required. Do not eat, drink or smoke when using this product. Ensure adequate ventilation.  	
	
7.2  Conditions for safe storage, including any incompatibilities  	
	Keep containers tightly closed in a dry, cool and well-ventilated place. Keep away from open flames, hot surfaces and sources of ignition. Keep container closed when not in use. Keep out of the reach of children.  	
	
7.3  Specific end use(s)  	
	Exposure scenario 	No information available.  	
	Risk Management Methods (RMM) 	The information required is contained in this Safety Data Sheet.  	
	
Section 8: EXPOSURE CONTROLS/PERSONAL PROTECTION 	
 	
8.1  Control parameters  	
	
Exposure limits
 	
Component 	The United Kingdom 	
Ethylene glycol monobutyl ether acetate 
 112-07-2 	STEL: 50 ppm 
STEL: 332 mg/m3 
TWA: 20 ppm 
TWA: 133 mg/m3 
Skin 	
Component 	France 	
Ethylene glycol monobutyl ether acetate 
 112-07-2 	TWA/VME: 10 ppm indicative limit 
TWA/VME: 66.5 mg/m3 indicative limit 
STEL/VLCT: 50 ppm restrictive limit 
STEL/VLCT: 333 mg/m3 restrictive limit 
Skin 	
Component 	Germany 	
Butyrolactone 
 96-48-0 	Skin 	
Ethylene glycol monobutyl ether acetate 
 112-07-2 	TWA/MAK: 10 ppm 
TWA/MAK: 66 mg/m3 
TWA/AGW: 10 ppm 
TWA/AGW: 65 mg/m3 
Peak: 20 ppm 
Peak: 132 mg/m3 
Skin 	
Dimethyl succinate 
 106-65-0 	TWA/AGW: 1.2 ppm 
TWA/AGW: 8 mg/m3 	
Dimethyl glutarate 
 1119-40-0 	TWA/AGW: 1.2 ppm 
TWA/AGW: 8 mg/m3 	
Component 	Spain 	
Ethylene glycol monobutyl ether acetate 
 112-07-2 	TWA/VLA-ED: 20 ppm 
TWA/VLA-ED: 133 mg/m3 
STEL/VLA-EC: 50 ppm 
STEL/VLA-EC: 333 mg/m3 
Skin 	
Component 	Italy 	
Ethylene glycol monobutyl ether acetate 
 112-07-2 	TWA: 20 ppm 
TWA: 133 mg/m3 
STEL: 50 ppm 
STEL: 333 mg/m3 
Skin 	
Component 	Portugal 	
Ethylene glycol monobutyl ether acetate 
 112-07-2 	TWA/VLE-MP: 20 ppm 
TWA/VLE-MP: 133 mg/m3 
STEL/VLE-CD: 50 ppm 
STEL/VLE-CD: 333 mg/m3 
Skin 	
Component 	The Netherlands 	
Ethylene glycol monobutyl ether acetate 
 112-07-2 	TWA: 135 mg/m3 
STEL: 333 mg/m3 
Skin 	
Component 	Finland 	
Butyrolactone 
 96-48-0 	TWA: 50 ppm 
TWA: 14 mg/m3 
STEL: 250 ppm 
STEL: 70 mg/m3 
Skin 	
Ethylene glycol monobutyl ether acetate 
 112-07-2 	TWA: 20 ppm 
TWA: 130 mg/m3 
STEL: 50 ppm 
STEL: 330 mg/m3 
Skin 	
Component 	Denmark 	
Ethylene glycol monobutyl ether acetate 
 112-07-2 	TWA: 20 ppm 
TWA: 134 mg/m3 
Skin 	
Component 	Austria 	
Ethylene glycol monobutyl ether acetate 
 112-07-2 	STEL/KZW: 40 ppm 
STEL/KZW: 270 mg/m3 
TWA/TMW: 20 ppm 
TWA/TMW: 133 mg/m3 
Skin 	
Component 	Switzerland 	
Ethylene glycol monobutyl ether acetate 
 112-07-2 	TWA/MAK: 10 ppm 
TWA/MAK: 66 mg/m3 
STEL/KZW: 20 ppm 
STEL/KZW: 132 mg/m3 
Skin 	
Component 	Poland 	
Ethylene glycol monobutyl ether acetate 
 112-07-2 	TWA/NDS: 100 mg/m3 
STEL/NDSCh : 300 mg/m3 	
Component 	Norway 	
Ethylene glycol monobutyl ether acetate 
 112-07-2 	TWA: 10 ppm 
TWA: 65 mg/m3 
Skin 	
Component 	Ireland 	
Ethylene glycol monobutyl ether acetate 
 112-07-2 	TWA: 20 ppm 
TWA: 133 mg/m3 
STEL: 50 ppm 
STEL: 333 mg/m3 
Skin 	
 	
Component 	Australia TWA 	
Ethylene glycol monobutyl ether acetate 
 112-07-2 	TWA: 20 ppm 
TWA: 133 mg/m3 	
Component 	Australia STEL 	
Ethylene glycol monobutyl ether acetate 
 112-07-2 	STEL: 50 ppm 
STEL: 333 mg/m3 	

Derived No Effect Level (DNEL) 	.  	
Component 	DNEL - Dermal 
(Workers) 	DNEL - Inhalation 
(Workers) 	
Diethylene glycol diethyl ether 
 112-36-7 	3.43 mg/kg 
(Systemic long term) 	50.05 mg/m3 
(Systemic long term) 	
Butyrolactone 
 96-48-0 	19 mg/kg 
(Systemic long term) 	130 mg/m3 
(Systemic long term) 
958 mg/m3 
(Systemic acute/short term) 	
Ethylene glycol monobutyl ether acetate 
 112-07-2 	169 mg/kg 
(Systemic long term) 
120 mg/kg 
(Systemic acute/short term) 	133 mg/m3 
(Systemic long term) 
333 mg/m3 
(Local acute/short term) 	
Triethylene glycol monobutyl ether 
 143-22-6 	208 mg/kg 
(Systemic long term) 	195 mg/m3 
(Systemic long term) 	
Dimethyl succinate 
 106-65-0 	6.3 mg/kg 
(Systemic long term) 
12.6 mg/kg 
(Systemic acute/short term)  	33.5m3 
(Systemic long term) 
67 mg/m3 
(Systemic acute/short term) 
1.1 mg/m3 
(Local long term) 
1.1 mg/m3 
(Local acute/short term)  	
Dimethyl glutarate 
 1119-40-0 	No data found 	8.3 mg/m3 
(Local long term) 	
Predicted No Effect Concentration (PNEC) 	No information available.  	
	
8.2  Exposure controls  	
	Engineering Measures 	Provide a good standard of general ventilation. Natural ventilation is from doors, windows etc. Controlled ventilation means air is supplied or removed by a powered fan. Users are advised to consider national Occupational Exposure Limits or other equivalent values. In case of insufficient ventilation, wear suitable respiratory equipment.  	
	
Personal protective equipment 		
	Eye/Face Protection 	Wear safety glasses with side shields (or goggles). If splashes are likely to occur:. Wear suitable face shield. Ensure that eyewash stations and safety showers are close to the workstation location.  	
	Skin Protection 	Wear impervious protective clothing, including boots, gloves, lab coat, apron or coveralls, as appropriate, to prevent skin contact.  	
	Respiratory Protection 	If exposure limits are exceeded or irritation is experienced, NIOSH/MSHA approved respiratory protection should be worn.  Respiratory protection must be provided in accordance with current local regulations.  	
	General Hygiene Considerations 	Handle in accordance with good industrial hygiene and safety practice. Wash hands before eating, drinking or smoking. Wash contaminated clothing before reuse. Avoid contact with eyes, skin and clothing. Wear suitable gloves and eye/face protection. Regular cleaning of equipment, work area and clothing is recommended.  	
		
Environmental exposure controls 	No information available.  	
	
Section 9: PHYSICAL AND CHEMICAL PROPERTIES 	
		
9.1  Information on basic physical and chemical properties  	
Physical State 	Liquid  	
	Appearance 	Colored  	
	
Odor 	No information available  	
	Odor Threshold 	No information available  	

Property 	Values  	
	Remarks  • Method  	
	
pH 		
	No data available  	
	
Melting Point / Freezing Point 		
	No data available  	
	
Boiling Point / Boiling Range 	>  149  °C  /  300  °F  	

Flash Point 	82  °C  /  180  °F  	
	Closed cup (Minimum)  	
	
Evaporation rate 		
	No data available  	
	
Flammability Limit in Air 		

	Upper flammability limit 		
	No data available  	
	
	Lower flammability limit 		
	No data available  	
	
Vapor Pressure 		
	No data available  	
	
Vapor Density 		
	No data available  	
	
Specific Gravity 	0.99  	

Water Solubility 		
	No data available  	
	
Solubility in other solvents 		
	No data available  	
	
Partition coefficient: n-octanol/water 		
	No data available  	
	
Autoignition Temperature 		
	No data available  	
	
Decomposition temperature 		
	No data available  	
	
Kinematic viscosity 		
	No data available  	
	
Dynamic viscosity 		
	No data available  	
	
Explosive Properties 	No data available  	
Oxidizing Properties 	No data available  	
		
9.2  Other information  	
Softening Point 	No data available  	
	
Section 10: STABILITY AND REACTIVITY 	
		
10.1  Reactivity  	
	No information available.  	
	
10.2  Chemical Stability  	
	Stable under normal conditions.  	
	
10.3  Possibility of Hazardous Reactions  	
	None under normal processing.  	
	
10.4  Conditions to avoid  	
	Keep away from open flames, hot surfaces and sources of ignition.  	
	
10.5  Incompatible materials  	
	Strong acids. Strong bases. Strong oxidizing agents. Reducing agent.  	
	
10.6  Hazardous decomposition products  	
	Thermal decomposition can lead to release of irritating gases and vapors. Carbon dioxide (CO2). Carbon monoxide.  	
	
Section 11: TOXICOLOGICAL INFORMATION 	
		
11.1  Information on toxicological effects  	
	
Acute Toxicity 		
	
	Inhalation 	Specific test data for the substance or mixture is not available.  	
	Eye Contact 	Specific test data for the substance or mixture is not available.  	
	Skin Contact 	Specific test data for the substance or mixture is not available.  	
	Ingestion 	Specific test data for the substance or mixture is not available.  	
		
Unknown Acute Toxicity 	0 % of the mixture consists of ingredient(s) of unknown toxicity.  	
	
The following values are calculated based on chapter 3.1 of the GHS document   	
	ATEmix (oral) 	2,043.00  	
	ATEmix (dermal) 	26,303.00  	
	ATEmix (inhalation-dust/mist) 	26.30  	
	ATEmix (inhalation-vapor) 	193.00  	
		
	Unknown Acute Toxicity  	
	0 % of the mixture consists of ingredient(s) of unknown toxicity.  	
	0 % of the mixture consists of ingredient(s) of unknown acute oral toxicity.  	
	0 % of the mixture consists of ingredient(s) of unknown acute dermal toxicity.  	
	0 % of the mixture consists of ingredient(s) of unknown acute inhalation toxicity (gas).  	
	0 % of the mixture consists of ingredient(s) of unknown acute inhalation toxicity (vapor).  	
	0 % of the mixture consists of ingredient(s) of unknown acute inhalation toxicity (dust/mist).  	

Component 	Oral LD50 	
Diethylene glycol diethyl ether 
 112-36-7 	= 4970 mg/kg  ( Rat ) 	
Butyrolactone 
 96-48-0 	= 1540 mg/kg  ( Rat ) 	
Ethylene glycol monobutyl ether acetate 
 112-07-2 	= 2400 mg/kg  ( Rat ) 	
Triethylene glycol monobutyl ether 
 143-22-6 	= 5300 mg/kg  ( Rat ) 	
Dimethyl succinate 
 106-65-0 	> 5 g/kg  ( Rat ) 	
Dimethyl glutarate 
 1119-40-0 	> 5000 mg/kg  ( Rat ) 	
		
Component 	Dermal LD50 	
Ethylene glycol monobutyl ether acetate 
 112-07-2 	= 1500 mg/kg  ( Rabbit ) 	
Triethylene glycol monobutyl ether 
 143-22-6 	> 2000 mg/kg  ( Rabbit ) 	
Dimethyl succinate 
 106-65-0 	> 5 g/kg  ( Rabbit ) 	
Dimethyl glutarate 
 1119-40-0 	> 5000 mg/kg  ( Rabbit ) 	
		
Component 	Inhalation LC50 	
Butyrolactone 
 96-48-0 	> 5100 mg/m3  ( Rat ) 4 h 	
Ethylene glycol monobutyl ether acetate 
 112-07-2 	> 400 ppm  ( Rat ) 4 h 	
Dimethyl glutarate 
 1119-40-0 	> 5.6 mg/L  ( Rat ) 4 h 	
 	
Skin corrosion/irritation 	Specific test data for the substance or mixture is not available.  	
Eye damage/irritation 	Specific test data for the substance or mixture is not available. Causes serious eye damage. (based on components).  	
Sensitization 	Specific test data for the substance or mixture is not available.  	
Mutagenic Effects 	Specific test data for the substance or mixture is not available.  	
Carcinogenic effects 	Specific test data for the substance or mixture is not available.  	
Reproductive Effects 	Specific test data for the substance or mixture is not available.  	
		
STOT - single exposure 	Specific test data for the substance or mixture is not available. May cause drowsiness or dizziness. (based on components).  	
STOT - repeated exposure 	Specific test data for the substance or mixture is not available.  	
Aspiration hazard 	Specific test data for the substance or mixture is not available.  	

Section 12: ECOLOGICAL INFORMATION 	
		
12.1  Toxicity  	
	Specific test data for the substance or mixture is not available.  	
	
	Unknown Aquatic Toxicity
0 % of the mixture consists of component(s) of unknown hazards to the aquatic environment  	
	
Component 	Algae/aquatic plants 	
Butyrolactone 
 96-48-0 	96h EC50 Desmodesmus subspicatus: = 79 mg/L 
72h EC50 Desmodesmus subspicatus: = 360 mg/L 	
Ethylene glycol monobutyl ether acetate 
 112-07-2 	72h EC50 Desmodesmus subspicatus: > 500 mg/L 	
Triethylene glycol monobutyl ether 
 143-22-6 	72h EC50 Desmodesmus subspicatus: > 500 mg/L 	
		
Component 	Fish 	
Triethylene glycol monobutyl ether 
 143-22-6 	96h LC50 Pimephales promelas: = 2400 mg/L 
96h LC50 Pimephales promelas: = 2400 mg/L (static) 	
Dimethyl succinate 
 106-65-0 	96h LC50 Brachydanio rerio:  50 - 100 mg/L (static) 	
Dimethyl glutarate 
 1119-40-0 	96h LC50 Pimephales promelas:  19.6 - 26.2 mg/L (static) 	
		
Component 	Crustacea 	
Butyrolactone 
 96-48-0 	48h EC50 Daphnia magna Straus: > 500 mg/L 	
Ethylene glycol monobutyl ether acetate 
 112-07-2 	48h EC50 Daphnia magna: = 37 mg/L 	
Triethylene glycol monobutyl ether 
 143-22-6 	48h EC50 Daphnia magna: > 500 mg/L 	
Dimethyl glutarate 
 1119-40-0 	48h EC50 Daphnia magna:  122.1 - 163.5 mg/L 	
		
12.2  Persistence and degradability  	
	No information available.  	
	
12.3  Bioaccumulative potential  	
	No information available.  	
Component 	Partition coefficient 	
Butyrolactone 
 96-48-0 	-0.566 	
Ethylene glycol monobutyl ether acetate 
 112-07-2 	1.51 	
Triethylene glycol monobutyl ether 
 143-22-6 	0.51 	
Dimethyl succinate 
 106-65-0 	0.19 	
		
12.4  Mobility in soil  	
	No information available.  	
	
12.5  Results of PBT and vPvB assessment  	
	This mixture contains no substance considered to be persistent, bioaccumulating nor toxic (PBT). This mixture contains no substance considered to be very persistent nor very bioaccumulating (vPvB).  	
		
12.6  Other adverse effects.  	
	No information available.  	

	
Section 13: DISPOSAL CONSIDERATIONS 	
		
13.1  Waste treatment methods  	
	Waste from residues/unused products 	Contain and dispose of waste according to local regulations.  	
	Contaminated Packaging 	Empty containers should be taken to an approved waste handling site for recycling or disposal.  	
	
Section 14: TRANSPORT INFORMATION 	
		
	Note: 	This information is not intended to convey all specific transportation requirements relating to this product. Transportation classifications may vary by container volume and may be influenced by regional or country variations in regulations. Additional transportation information can be found in the specific regulations for your mode of transportation.  It is the responsibility of the transporting organization to follow all applicable laws, regulations and rules relating to the transportation of the material.  	
		
ADR 	Not Regulated  	
14.2  Proper Shipping Name 	Printing Ink  	
		
ICAO / IATA / IMDG / IMO 	Not Regulated  	
14.2  Proper Shipping Name 	Printing Ink  	

	
Section 15: REGULATORY INFORMATION 	
		
15.1  Safety, health and environmental regulations/legislation specific for the substance or mixture  	

		
European Union 		
	
International Inventories
For further information, please contact: Supplier (manufacturer/importer/downstream user/distributor)  	

15.2  Chemical Safety Assessment  	
No information available.  	
	
Section 16: OTHER INFORMATION 	
		
Key or legend to abbreviations and acronyms used in the safety data sheet

Full text of H-Statements referred to under sections 2 and 3
H302 - Harmful if swallowed
H312 - Harmful in contact with skin
H318 - Causes serious eye damage
H319 - Causes serious eye irritation
H332 - Harmful if inhaled
H336 - May cause drowsiness or dizziness  	
	
Legend  - Section 8: EXPOSURE CONTROLS/PERSONAL PROTECTION  	
TWA 	TWA (time-weighted average)  	
STEL 	STEL (Short Term Exposure Limit)  	
Ceiling 	Maximum limit value  	
		
Revision Date 	Mar-08-2019  	
	
This safety data sheet complies with the requirements of Regulation (EC) No. 1907/2006  	
	
Disclaimer
The information provided in this Safety Data Sheet is correct to the best of our knowledge, information and belief at the date of its publication. The information given is designed only as a guidance for safe handling, use, processing, storage, transportation, disposal and release and is not to be considered a warranty or quality specification. The information relates only to the specific material designated and may not be valid for such material used in combination with any other materials or in any process, unless specified in the text.  	
	
End of Safety Data Sheet